EUVIMEDEUVIMED entdecken
Open Access

Chemokine‐Guided Biomimetic Mn/Ce Nanozymes for Immunomodulation and Cardioprotection in Doxorubicin‐Induced Cardiomyopathy

Zhi-Nan Wang, Xi Liu, Shidong Hu, Shuo Geng, Ding Yang, Kun Zhang, Xiao-Ting Li, Bingwen Zheng, Xiaowei Zhu, Ying-Shi Sun iD

Advanced Healthcare Materials · 2026-07 · 15 (27)

DOI: 10.1002/adhm.71347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 11.06.2026. Verfasst von Zhi-Nan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Radiology, Peking University Cancer Hospital & Inst…. Hauptthemen laut MEDLINE: Doxorubicin, Cardiomyopathies, Biomimetic Materials, Cardiotonic Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Science Foundation of Peking University Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin‐induced cardiomyopathy (DIC) remains a major dose‐limiting complication of anthracycline chemotherapy, with no effective targeted therapies available. Emerging evidence suggests that maladaptive inflammation, driven by aberrant monocyte recruitment, synergizes with oxidative stress to exacerbate myocardial injury. In particular, the CCL2‐CCR2 chemokine axis plays a pivotal role in inflammatory cell trafficking and disease progression. An engineered biomimetic nanozyme, termed CCR2‐MM@Mn/CeZ, is developed for inflammation‐targeted cardioprotection. This platform comprises a Mn/Ce co‐doped ZIF‐8 nanozyme core with intrinsic antioxidant activity, cloaked by macrophage membranes (MM) overexpressing CCR2. This design enables selective homing to inflamed myocardium via CCL2 recognition, prolonged cardiac retention, and simultaneous modulation of inflammatory and oxidative microenvironments. In a DIC mouse model, CCR2‐MM@Mn/CeZ significantly enhances myocardial accumulation, suppresses pro‐inflammatory macrophage infiltration, promotes M2 polarization, and reduces intracellular reactive oxygen species. Transcriptomic analysis further reveals coordinated downregulation of inflammatory pathways and restoration of redox and metabolic homeostasis. Meanwhile, Mn 2+ ‐mediated T1‐weighted magnetic resonance imaging enables noninvasive visualization of myocardial targeting. Collectively, this chemokine‐axis‐guided biomimetic nanozyme integrates targeted delivery, immunomodulation, oxidative stress suppression, and diagnostic imaging, offering a promising strategy for DIC theranostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiomyopathiesBiomimetic MaterialsCardiotonic AgentsImmunomodulationChemokinesNanoparticlesAnimalsMiceReceptors, CCR2MacrophagesOxidative StressChemokine CCL2MyocardiumMice, Inbred C57BL

Stichwörter der Autor:innen

CCL2–CCR2 chemokine axisbiomimetic nanoparticlesdoxorubicin‐induced cardiomyopathymacrophage polarizationoxidative stress modulationtheranostics

Substanzen

DoxorubicinReceptors, CCR2Cardiotonic AgentsChemokinesChemokine CCL2Ccr2 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Senior Department of General Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
  • State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai, China.
  • Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Children's Medicine Key Laboratory of Sichuan Province, West China Second…
  • Time Medical Ltd., Hong Kong Science & Technology Park, Hong Kong, China.
  • Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Ying-Shi Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality
  • Science Foundation of Peking University Cancer Hospital

Zitieren

APA

Wang, Z. N., Liu, X., Hu, S., Geng, S., Yang, D., Zhang, K., Li, X. T., Zheng, B., Zhu, X., & Sun, Y. S. (2026). Chemokine‐Guided Biomimetic Mn/Ce Nanozymes for Immunomodulation and Cardioprotection in Doxorubicin‐Induced Cardiomyopathy. Advanced Healthcare Materials, 15(27). https://doi.org/10.1002/adhm.71347

Vancouver

Wang ZN, Liu X, Hu S, Geng S, Yang D, Zhang K, et al. Chemokine‐Guided Biomimetic Mn/Ce Nanozymes for Immunomodulation and Cardioprotection in Doxorubicin‐Induced Cardiomyopathy. Advanced Healthcare Materials. 2026;15(27). doi:10.1002/adhm.71347

BibTeX
@article{Wang2026,
  author = {Wang, Zhi-Nan and Liu, Xi and Hu, Shidong and Geng, Shuo and Yang, Ding and Zhang, Kun and Li, Xiao-Ting and Zheng, Bingwen and Zhu, Xiaowei and Sun, Ying-Shi},
  title = {Chemokine‐Guided Biomimetic Mn/Ce Nanozymes for Immunomodulation and Cardioprotection in Doxorubicin‐Induced Cardiomyopathy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {27},
  doi = {10.1002/adhm.71347}
}
Kostenlos starten →